Weiss Multi Strategy Advisers LLC Lyell Immunopharma, Inc. Transaction History

Weiss Multi Strategy Advisers LLC

  • $0
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$7.13 - $15.19 $104,811 - $223,293
-14,700 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$11.0 - $17.95 $113,300 - $184,885
-10,300 Reduced 41.2%
14,700 $218,000
Q2 2021

Aug 16, 2021
BUY
$15.99 - $16.89 $399,750 - $422,250
25,000 New
25,000 $406,000

Others Institutions Holding LYEL

# of Institutions
122
Shares Held
142M
Call Options Held
18.1K
Put Options Held
200
View Full List

About Lyell Immunopharma, Inc.

LYEL Quotes by TradingView
  • Ticker LYEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 247,824,992
  • Market Cap $235M
  • Description
  • Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...
More about LYEL
Track This Portfolio

Track Weiss Multi Strategy Advisers LLC Portfolio

Follow Weiss Multi Strategy Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email